← Leaderboards
Melissa A Kacena
Indiana University Indianapolis
$7,991,370
Attributed
$13,072,364
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,072,364 · 10
VA$0 · 5
By mechanism
R01$12,723,876 · 8
R03$223,688 · 1
R56$124,800 · 1
I01$0 · 3
IK6$0 · 1
IS1$0 · 1
Top collaborators
- Jiliang Li8 shared
- Edward F Srour7 shared
- Angela Bruzzaniti6 shared
- Louis M Pelus6 shared
- Alexander G. Obukhov2 shared
- Fletcher A White2 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Jiliang Li$2,219,019
- Angela Bruzzaniti$3,717,963
- Stacey L. Halum$7,675,024
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsOsteoblastsBoneMegakaryocytesBaseFractureRegulationBone LossDefectHematopoieticBone HealingPainMediatingOperative Surgical ProceduresPathway InteractionsBone MarrowHealingInjuryBone RegenerationOsteogenesisSignal TransductionEndothelial CellsImpairmentOrthopedics
Grant awards (56)
Novel treatments of fracture repair and bone pain$551,117
R01 · FY2025 · AR
RR&D Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Thrombopoietin Mimetic Peptides for Treatment of Fractures$0
I01 · FY2025 · VA · contact PI
"Novel therapeutic approaches to improve fracture healing while reducing pain behavior"$0
I01 · FY2025 · VA · contact PI
RR&D Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Novel treatments of fracture repair and bone pain$608,358
R01 · FY2024 · AR
Thrombopoietin Mimetic Peptides for Treatment of Fractures$0
I01 · FY2024 · VA · contact PI
"Novel therapeutic approaches to improve fracture healing while reducing pain behavior"$0
I01 · FY2024 · VA · contact PI
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging$551,292
R01 · FY2023 · AG · contact PI
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging - AD/ADRD$396,250
R01 · FY2023 · AG · contact PI
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging - LOAD$396,250
R01 · FY2023 · AG · contact PI
CD166 Regulates Human and Murine Hematopoietic Stem Cell Function and the Hematopoietic Niche$354,375
R01 · FY2023 · DK · contact PI
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function$317,000
R01 · FY2023 · AG · contact PI
RR&D Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
"Novel therapeutic approaches to improve fracture healing while reducing pain behavior"$0
I01 · FY2023 · VA · contact PI
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging$551,292
R01 · FY2022 · AG · contact PI
CD166 Regulates Human and Murine Hematopoietic Stem Cell Function and the Hematopoietic Niche$354,375
R01 · FY2022 · DK · contact PI
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function$317,000
R01 · FY2022 · AG · contact PI
"Novel therapeutic approaches to improve fracture healing while reducing pain behavior"$0
I01 · FY2022 · VA · contact PI
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging$563,690
R01 · FY2021 · AG · contact PI
CD166 Regulates Human and Murine Hematopoietic Stem Cell Function and the Hematopoietic Niche$354,375
R01 · FY2021 · DK
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function$317,000
R01 · FY2021 · DK
Impact of TPO Treatment on Bone Healing and Angiogenesis in Type 2 Diabetes$0
I01 · FY2021 · VA · contact PI
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging$584,950
R01 · FY2020 · AG · contact PI
CD166 Regulates Human and Murine Hematopoietic Stem Cell Function and the Hematopoietic Niche$354,375
R01 · FY2020 · DK
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function$317,000
R01 · FY2020 · DK
Impact of TPO Treatment on Bone Healing and Angiogenesis in Type 2 Diabetes$0
I01 · FY2020 · VA · contact PI
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging$618,796
R01 · FY2019 · AG · contact PI
CD166 Regulates Human and Murine Hematopoietic Stem Cell Function and the Hematopoietic Niche$354,375
R01 · FY2019 · DK
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function$317,000
R01 · FY2019 · DK
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging$13,217
R01 · FY2019 · AG · contact PI
ShEEP Request for a Kubtec XPERT 80 Shielded Cabinet X-ray System$0
IS1 · FY2019 · VA · contact PI
Impact of TPO Treatment on Bone Healing and Angiogenesis in Type 2 Diabetes$0
I01 · FY2019 · VA · contact PI
Impact of TPO Treatment on Bone Healing and Angiogenesis in Type 2 Diabetes$0
I01 · FY2018 · VA · contact PI
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$195,000
R01 · FY2017 · AG
Impact of TPO Treatment on Bone Healing and Angiogenesis in Type 2 Diabetes$0
I01 · FY2017 · VA · contact PI
Thrombopoietin: A novel regulator of bone healing$351,000
R01 · FY2016 · AR · contact PI
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$195,000
R01 · FY2016 · AG
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$100,000
R01 · FY2016 · AG
Thrombopoietin: A novel regulator of bone healing$351,000
R01 · FY2015 · AR · contact PI
Regulation of Osteoblast Function by Megakaryocytes: Key Signaling Proteins$346,500
R01 · FY2015 · AR · contact PI
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$189,150
R01 · FY2015 · AG
CD166 Regulates Human and Murine Hematopoietic Stem Cell Function and the Hematopoietic Niche$124,800
R56 · FY2015 · DK
Thrombopoietin: A novel regulator of bone healing$343,980
R01 · FY2014 · AR · contact PI
Regulation of Osteoblast Function by Megakaryocytes: Key Signaling Proteins$339,570
R01 · FY2014 · AR · contact PI
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$195,000
R01 · FY2014 · AG
Thrombopoietin: A novel regulator of bone healing$333,450
R01 · FY2013 · AR · contact PI
Regulation of Osteoblast Function by Megakaryocytes: Key Signaling Proteins$329,175
R01 · FY2013 · AR · contact PI
A megakaryocyte/PGE2/osteoblast triad in the normal and aged niche$195,000
R01 · FY2013 · AG
Thrombopoietin: A novel regulator of bone healing$351,000
R01 · FY2012 · AR · contact PI
Regulation of Osteoblast Function by Megakaryocytes: Key Signaling Proteins$346,500
R01 · FY2012 · AR · contact PI
Regulation of Osteoblast Function by Megakaryocytes: Key Signaling Proteins$23,964
R01 · FY2012 · AR · contact PI
Regulation of Osteoblast Function by Megakaryocytes: Key Signaling Proteins$346,500
R01 · FY2011 · AR · contact PI
The Role of OPG in GATA-1 Deficiency$73,990
R03 · FY2009 · AR · contact PI
The Role of OPG in GATA-1 Deficiency$73,990
R03 · FY2008 · AR · contact PI
The Role of OPG in GATA-1 Deficiency$75,708
R03 · FY2007 · AR · contact PI